According to FutureWise analysis the market for Humanized Liver Mice Model in 2023 is US$ 0.09 billion, and is expected to reach US$ 0.14 billion by 2031 at a CAGR of 6.34%.
To improve the understanding of mammalian and human genome function and have effective therapies designed, humanized liver mice market plays a vital role. The rising need for development and efficient research and useful results, the global market for humanized liver mice is growing. High expenses and technical requirements may restrict the market.
Rapid modernisation which promotes the genetic engineering of mouse genomes such as the development of knock-out mouse, knock-in mouse as well as the transgenic mouse has led to lucrative trade. To encourage the robust genetic modification of mice, advancements in technology are rapid, which promotes the engineering of new immune-deficient mice models for capitalizing on the discovery of novel approaches to enhance the engraftment of human cells or tissues. Engrafting the mouse liver with human hepatocytes and mouse bone marrow with human hematopoietic stem cells is a great discovery, expected to propel the market.
The developed nations have higher research facilities and thus the market finds great application there. Markets of North America and Europe are high growth pockets and are predicted to grow at highest CAGR during the forecast period.
Market palyers are incessantly competing for a significant value share and expansion of their global outreach by investing in technologies.